Glycyrol targets Pneumolysin (PLY) oligomerization to reduce Streptococcus pneumoniae toxicity

Exploring the potential of glycyrol to reduce the invasiveness of ( ). Cell experiments were performed using A549 alveolar epithelial cells and D39. Glycyrol was added to A549 cells mixed with or without Pneumolysin (PLY) to detect the effect of Glycyrol on PLY toxicity. Glycyrol was used to detect...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in pharmacology Vol. 15; p. 1478135
Main Authors Li, Yudi, Wu, Hongji, Hu, Yibo, Meng, Haoji, Xu, Yan
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 03.12.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Exploring the potential of glycyrol to reduce the invasiveness of ( ). Cell experiments were performed using A549 alveolar epithelial cells and D39. Glycyrol was added to A549 cells mixed with or without Pneumolysin (PLY) to detect the effect of Glycyrol on PLY toxicity. Glycyrol was used to detect the effect on S. pneumoniae toxicity and PLY production. Mice was used to detect the anti-infectious ability of Glycyrol to regulate infection. Western blot and Molecular docking were used to detect how and where Glycyrol inhibits PLY toxicity. We discovered that glycyrol, a main component of the widely recognized Chinese herbal medicine licorice, reduce the virulence of PLY in invasion; glycyrol achieves this effect by interacting with PLY through hydrogen bonding, van der Waals interactions, and solvation effects to reduce the pore-forming toxicity of PLY. Moreover, glycyrol did not affect the growth of or the production of PLY. We have actually discovered that Glycyrol, a major component of the widely known Chinese herbal medicine Fisch., interacts with PLY through hydrogen bonds, Van der Waals and solvation to reduce the pore-forming toxicity of PLY and the toxicity of invasion, while not affecting the growth of and the production of PLY.
AbstractList Aim of the studyExploring the potential of glycyrol to reduce the invasiveness of Streptococcus pneumoniae (S. pneumoniae).Materials and MethodsCell experiments were performed using A549 alveolar epithelial cells and S. pneumoniae D39. Glycyrol was added to A549 cells mixed with or without Pneumolysin (PLY) to detect the effect of Glycyrol on PLY toxicity. Glycyrol was used to detect the effect on S. pneumoniae toxicity and PLY production. Mice was used to detect the anti-infectious ability of Glycyrol to regulate S. pneumoniae infection. Western blot and Molecular docking were used to detect how and where Glycyrol inhibits PLY toxicity.ResultsWe discovered that glycyrol, a main component of the widely recognized Chinese herbal medicine licorice, reduce the virulence of PLY in S. pneumoniae invasion; glycyrol achieves this effect by interacting with PLY through hydrogen bonding, van der Waals interactions, and solvation effects to reduce the pore-forming toxicity of PLY. Moreover, glycyrol did not affect the growth of S. pneumoniae or the production of PLY.ConclusionWe have actually discovered that Glycyrol, a major component of the widely known Chinese herbal medicine Glycyrrhiza uralensis Fisch., interacts with PLY through hydrogen bonds, Van der Waals and solvation to reduce the pore-forming toxicity of PLY and the toxicity of S. pneumoniae invasion, while not affecting the growth of S. pneumoniae and the production of PLY.
Exploring the potential of glycyrol to reduce the invasiveness of ( ). Cell experiments were performed using A549 alveolar epithelial cells and D39. Glycyrol was added to A549 cells mixed with or without Pneumolysin (PLY) to detect the effect of Glycyrol on PLY toxicity. Glycyrol was used to detect the effect on S. pneumoniae toxicity and PLY production. Mice was used to detect the anti-infectious ability of Glycyrol to regulate infection. Western blot and Molecular docking were used to detect how and where Glycyrol inhibits PLY toxicity. We discovered that glycyrol, a main component of the widely recognized Chinese herbal medicine licorice, reduce the virulence of PLY in invasion; glycyrol achieves this effect by interacting with PLY through hydrogen bonding, van der Waals interactions, and solvation effects to reduce the pore-forming toxicity of PLY. Moreover, glycyrol did not affect the growth of or the production of PLY. We have actually discovered that Glycyrol, a major component of the widely known Chinese herbal medicine Fisch., interacts with PLY through hydrogen bonds, Van der Waals and solvation to reduce the pore-forming toxicity of PLY and the toxicity of invasion, while not affecting the growth of and the production of PLY.
Exploring the potential of glycyrol to reduce the invasiveness of Streptococcus pneumoniae (S. pneumoniae).Aim of the studyExploring the potential of glycyrol to reduce the invasiveness of Streptococcus pneumoniae (S. pneumoniae).Cell experiments were performed using A549 alveolar epithelial cells and S. pneumoniae D39. Glycyrol was added to A549 cells mixed with or without Pneumolysin (PLY) to detect the effect of Glycyrol on PLY toxicity. Glycyrol was used to detect the effect on S. pneumoniae toxicity and PLY production. Mice was used to detect the anti-infectious ability of Glycyrol to regulate S. pneumoniae infection. Western blot and Molecular docking were used to detect how and where Glycyrol inhibits PLY toxicity.Materials and MethodsCell experiments were performed using A549 alveolar epithelial cells and S. pneumoniae D39. Glycyrol was added to A549 cells mixed with or without Pneumolysin (PLY) to detect the effect of Glycyrol on PLY toxicity. Glycyrol was used to detect the effect on S. pneumoniae toxicity and PLY production. Mice was used to detect the anti-infectious ability of Glycyrol to regulate S. pneumoniae infection. Western blot and Molecular docking were used to detect how and where Glycyrol inhibits PLY toxicity.We discovered that glycyrol, a main component of the widely recognized Chinese herbal medicine licorice, reduce the virulence of PLY in S. pneumoniae invasion; glycyrol achieves this effect by interacting with PLY through hydrogen bonding, van der Waals interactions, and solvation effects to reduce the pore-forming toxicity of PLY. Moreover, glycyrol did not affect the growth of S. pneumoniae or the production of PLY.ResultsWe discovered that glycyrol, a main component of the widely recognized Chinese herbal medicine licorice, reduce the virulence of PLY in S. pneumoniae invasion; glycyrol achieves this effect by interacting with PLY through hydrogen bonding, van der Waals interactions, and solvation effects to reduce the pore-forming toxicity of PLY. Moreover, glycyrol did not affect the growth of S. pneumoniae or the production of PLY.We have actually discovered that Glycyrol, a major component of the widely known Chinese herbal medicine Glycyrrhiza uralensis Fisch., interacts with PLY through hydrogen bonds, Van der Waals and solvation to reduce the pore-forming toxicity of PLY and the toxicity of S. pneumoniae invasion, while not affecting the growth of S. pneumoniae and the production of PLY.ConclusionWe have actually discovered that Glycyrol, a major component of the widely known Chinese herbal medicine Glycyrrhiza uralensis Fisch., interacts with PLY through hydrogen bonds, Van der Waals and solvation to reduce the pore-forming toxicity of PLY and the toxicity of S. pneumoniae invasion, while not affecting the growth of S. pneumoniae and the production of PLY.
Author Li, Yudi
Hu, Yibo
Wu, Hongji
Xu, Yan
Meng, Haoji
AuthorAffiliation 2 School of Pediatrics , Henan University of Chinese Medicine , Zhengzhou , Henan , China
1 Department of Pediatrics , The First Affiliated Hospital of Henan University of Chinese Medicine , Zhengzhou , Henan , China
AuthorAffiliation_xml – name: 2 School of Pediatrics , Henan University of Chinese Medicine , Zhengzhou , Henan , China
– name: 1 Department of Pediatrics , The First Affiliated Hospital of Henan University of Chinese Medicine , Zhengzhou , Henan , China
Author_xml – sequence: 1
  givenname: Yudi
  surname: Li
  fullname: Li, Yudi
– sequence: 2
  givenname: Hongji
  surname: Wu
  fullname: Wu, Hongji
– sequence: 3
  givenname: Yibo
  surname: Hu
  fullname: Hu, Yibo
– sequence: 4
  givenname: Haoji
  surname: Meng
  fullname: Meng, Haoji
– sequence: 5
  givenname: Yan
  surname: Xu
  fullname: Xu, Yan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39691402$$D View this record in MEDLINE/PubMed
BookMark eNpVkk9v1DAQxS1UREvpF-CAciyHXfwnTuwTQhUtlVaiEnDgguWMJ1tXSRxsB5F-etLdpWp9GWvmze9J9ntNjoYwICFvGV0LofSHdry1cc0pL9esrBUT8gU5YVUlVloxfvTkfkzOUrqjyxFai6p8RY6FrjQrKT8hv666GeYYuiLbuMWcipsBpz50c_JDcX6z-fm-CJ3fhh6jv7fZh6HIoYjoJsDiW4445gABYErFuNscvMVF8teDz_Mb8rK1XcKzQz0lPy4_f7_4stp8vbq--LRZQclpXoF0UDc1oG3LxlGk0OjWKeeo1khRKiWEbeQyL6uGO6cs5ZILqxqlQIMUp-R6z3XB3pkx-t7G2QTrza4R4tbYmD10aCRQZmtLW6n1Ys6btmoZVqp2TnBguLA-7lnj1PToAIccbfcM-nwy-FuzDX8MY5Wky7MuhPMDIYbfE6Zsep8Au84OGKZkBCsrLWmp60X67qnZo8v_H1oEfC-AGFKK2D5KGDUPSTC7JJiHJJhDEsQ_IqiqkA
Cites_doi 10.1093/infdis/jis336
10.3390/ijms222111401
10.1080/21505594.2017.1313372
10.1146/annurev-med-080219-122208
10.1016/j.carbpol.2020.117108
10.1093/jac/dkv038
10.3390/toxins10100385
10.1111/jam.14769
10.1016/S1473-3099(18)30513-9
10.1016/j.chom.2016.12.005
10.1016/j.jep.2021.114133
10.3390/molecules22091430
10.3390/ijms231911740
10.1073/pnas.0606795103
10.1016/j.chembiol.2016.02.010
10.2147/IJN.S24805
10.1016/j.fct.2014.10.023
10.1186/s12877-022-03257-3
10.3109/13880200903573169
10.13758/j.cnki.tr.2020.05.004
10.1089/sur.2018.184
10.1021/np058069d
10.1038/s41579-018-0001-8
10.1016/j.bcp.2016.09.018
10.1016/j.cell.2005.02.033
10.3390/antibiotics7030066
10.1016/j.cmi.2019.09.015
10.1007/s12272-016-0824-7
ContentType Journal Article
Copyright Copyright © 2024 Li, Wu, Hu, Meng and Xu.
Copyright © 2024 Li, Wu, Hu, Meng and Xu. 2024 Li, Wu, Hu, Meng and Xu
Copyright_xml – notice: Copyright © 2024 Li, Wu, Hu, Meng and Xu.
– notice: Copyright © 2024 Li, Wu, Hu, Meng and Xu. 2024 Li, Wu, Hu, Meng and Xu
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fphar.2024.1478135
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals (DOAJ) (Open Access)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate Li et al
EISSN 1663-9812
ExternalDocumentID oai_doaj_org_article_5c01a7a0f5994202bf6f1e687dd32c1e
PMC11650140
39691402
10_3389_fphar_2024_1478135
Genre Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
O5R
O5S
OK1
P2P
PGMZT
RNS
RPM
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c420t-c5dc7b7ceaf4bd0e0cb9fd8dd099e0e58833ab5cea46b2dd8a02523a8b88c9c53
IEDL.DBID M48
ISSN 1663-9812
IngestDate Wed Aug 27 01:08:20 EDT 2025
Thu Aug 21 18:29:19 EDT 2025
Fri Jul 11 09:19:36 EDT 2025
Sun Mar 30 02:12:19 EDT 2025
Tue Jul 01 01:11:46 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords toxicity
PLY
glycyrol
Streptococcus pneumoniae
TCM
Language English
License Copyright © 2024 Li, Wu, Hu, Meng and Xu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c420t-c5dc7b7ceaf4bd0e0cb9fd8dd099e0e58833ab5cea46b2dd8a02523a8b88c9c53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Josué Arturo Velázquez-Moyado, National Autonomous University of Mexico, Mexico
Edited by: Carlos L. Cespedes-Acuña, University of Bio Bio Chillan Chile, Chile
Reviewed by: Habibu Tijjani, National Open University of Nigeria, Nigeria
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fphar.2024.1478135
PMID 39691402
PQID 3146950497
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_5c01a7a0f5994202bf6f1e687dd32c1e
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11650140
proquest_miscellaneous_3146950497
pubmed_primary_39691402
crossref_primary_10_3389_fphar_2024_1478135
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-12-03
PublicationDateYYYYMMDD 2024-12-03
PublicationDate_xml – month: 12
  year: 2024
  text: 2024-12-03
  day: 03
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in pharmacology
PublicationTitleAlternate Front Pharmacol
PublicationYear 2024
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Fang (B5) 2016
Qiu (B18) 2012; 206
Theuretzbacher (B24) 2019; 19
Vila (B26) 2020; 26
Zafar (B29) 2017; 21
Jarczak (B10) 2022; 23
Rashki (B19) 2021; 251
Rohde (B21) 2018; 19
Seil (B23) 2012; 7
Hatfull (B7) 2022; 73
Rhew (B20) 2016; 39
Alam (B2) 2016; 23
Huang (B9) 2020; 52
Molchanova (B14) 2017; 22
Li (B11) 2010; 48
Qi (B17) 2021; 130
Tilley (B25) 2005; 121
Domingo-Calap (B4) 2018; 7
Xu (B28) 2014; 74
Díez-Martínez (B3) 2015; 70
Guo (B6) 2021; 275
He (B8) 2006; 69
Weiser (B27) 2018; 16
Ageitos (B1) 2017; 133
Ouyang (B15) 2018; 10
Luo (B13) 2021; 22
Roy (B22) 2018; 9
Zhang (B30) 2022; 22
Pinkner (B16) 2006; 103
References_xml – volume: 206
  start-page: 292
  year: 2012
  ident: B18
  article-title: Baicalin protects mice from Staphylococcus aureus pneumonia via inhibition of the cytolytic activity of α-hemolysin
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jis336
– volume: 22
  start-page: 11401
  year: 2021
  ident: B13
  article-title: Mechanism of antimicrobial peptides: antimicrobial, anti-inflammatory and antibiofilm activities
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms222111401
– volume: 9
  start-page: 522
  year: 2018
  ident: B22
  article-title: Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action
  publication-title: Virulence
  doi: 10.1080/21505594.2017.1313372
– volume: 73
  start-page: 197
  year: 2022
  ident: B7
  article-title: Phage therapy for antibiotic-resistant bacterial infections
  publication-title: Annu. Rev. Med.
  doi: 10.1146/annurev-med-080219-122208
– volume: 251
  start-page: 117108
  year: 2021
  ident: B19
  article-title: Chitosan-based nanoparticles against bacterial infections
  publication-title: Carbohydr. Polym.
  doi: 10.1016/j.carbpol.2020.117108
– volume: 70
  start-page: 1763
  year: 2015
  ident: B3
  article-title: A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae
  publication-title: J. Antimicrob. Chemother.
  doi: 10.1093/jac/dkv038
– volume: 10
  start-page: 385
  year: 2018
  ident: B15
  article-title: Erianin against Staphylococcus aureus infection via inhibiting sortase A
  publication-title: Toxins (Basel)
  doi: 10.3390/toxins10100385
– volume: 130
  start-page: 843
  year: 2021
  ident: B17
  article-title: Betulin attenuates pneumolysin-induced cell injury and DNA damage
  publication-title: J. Appl. Microbiol.
  doi: 10.1111/jam.14769
– volume: 19
  start-page: e40
  year: 2019
  ident: B24
  article-title: Analysis of the clinical antibacterial and antituberculosis pipeline
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(18)30513-9
– volume: 21
  start-page: 73
  year: 2017
  ident: B29
  article-title: Host-to-Host transmission of Streptococcus pneumoniae is driven by its inflammatory toxin, pneumolysin
  publication-title: Pneumolysin. Cell Host Microbe
  doi: 10.1016/j.chom.2016.12.005
– volume: 275
  start-page: 114133
  year: 2021
  ident: B6
  article-title: The TCM prescription Ma-xing-shi-gan-tang inhibits Streptococcus pneumoniae pathogenesis by targeting pneumolysin
  publication-title: J. Ethnopharmacol.
  doi: 10.1016/j.jep.2021.114133
– start-page: 2
  year: 2016
  ident: B5
  article-title: It’s time for the Chinese to say no to the abuse of antibiotics in animals and plants Chinese famous plant ecologist Jiang Gaoming talks about antibiotics in the ecological chain
  publication-title: Cap. Food Med.
– volume: 22
  start-page: 1430
  year: 2017
  ident: B14
  article-title: Advances in development of antimicrobial peptidomimetics as potential drugs
  publication-title: Molecules
  doi: 10.3390/molecules22091430
– volume: 23
  start-page: 11740
  year: 2022
  ident: B10
  article-title: Cytokine storm-definition, causes, and implications
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms231911740
– volume: 103
  start-page: 17897
  year: 2006
  ident: B16
  article-title: Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0606795103
– volume: 23
  start-page: 381
  year: 2016
  ident: B2
  article-title: RecA inhibitors potentiate antibiotic activity and block evolution of antibiotic resistance
  publication-title: Cell Chem. Biol.
  doi: 10.1016/j.chembiol.2016.02.010
– volume: 7
  start-page: 2767
  year: 2012
  ident: B23
  article-title: Antimicrobial applications of nanotechnology: methods and literature
  publication-title: Int. J. Nanomedicine
  doi: 10.2147/IJN.S24805
– volume: 74
  start-page: 311
  year: 2014
  ident: B28
  article-title: Antitumor activity of glycyrol via induction of cell cycle arrest, apoptosis and defective autophagy
  publication-title: Food Chem. Toxicol.
  doi: 10.1016/j.fct.2014.10.023
– volume: 22
  start-page: 562
  year: 2022
  ident: B30
  article-title: Early use of probiotics might prevent antibiotic-associated diarrhea in elderly (>65 years): a systematic review and meta-analysis
  publication-title: BMC Geriatr.
  doi: 10.1186/s12877-022-03257-3
– volume: 48
  start-page: 1177
  year: 2010
  ident: B11
  article-title: Immunosuppressive activity on the murine immune responses of glycyrol from Glycyrrhiza uralensis via inhibition of calcineurin activity
  publication-title: Pharm. Biol.
  doi: 10.3109/13880200903573169
– volume: 52
  start-page: 10
  year: 2020
  ident: B9
  article-title: Research progress on the migration, transformation and resistance reduction of antibiotics/resistant bacteria/resistant genes in the soil-plant system
  publication-title: Soil
  doi: 10.13758/j.cnki.tr.2020.05.004
– volume: 19
  start-page: 737
  year: 2018
  ident: B21
  article-title: Bacteriophages: a therapy concept against multi-drug-resistant bacteria
  publication-title: Surg. Infect. (Larchmt)
  doi: 10.1089/sur.2018.184
– volume: 69
  start-page: 121
  year: 2006
  ident: B8
  article-title: Antibacterial compounds from Glycyrrhiza uralensis
  publication-title: J. Nat. Prod.
  doi: 10.1021/np058069d
– volume: 16
  start-page: 355
  year: 2018
  ident: B27
  article-title: Streptococcus pneumoniae: transmission, colonization and invasion
  publication-title: Nat. Rev. Microbiol.
  doi: 10.1038/s41579-018-0001-8
– volume: 133
  start-page: 117
  year: 2017
  ident: B1
  article-title: Antimicrobial peptides (AMPs): ancient compounds that represent novel weapons in the fight against bacteria
  publication-title: Biochem. Pharmacol.
  doi: 10.1016/j.bcp.2016.09.018
– volume: 121
  start-page: 247
  year: 2005
  ident: B25
  article-title: Structural basis of pore formation by the bacterial toxin pneumolysin
  publication-title: Cell.
  doi: 10.1016/j.cell.2005.02.033
– volume: 7
  start-page: 66
  year: 2018
  ident: B4
  article-title: Bacteriophages: protagonists of a post-antibiotic era
  publication-title: Antibiot. (Basel).
  doi: 10.3390/antibiotics7030066
– volume: 26
  start-page: 596
  year: 2020
  ident: B26
  article-title: Current landscape in the discovery of novel antibacterial agents
  publication-title: Clin. Microbiol. Infect.
  doi: 10.1016/j.cmi.2019.09.015
– volume: 39
  start-page: 1482
  year: 2016
  ident: B20
  article-title: Synergic effect of combination of glycyrol and fluconazole against experimental cutaneous candidiasis due to Candida albicans
  publication-title: Arch. Pharm. Res.
  doi: 10.1007/s12272-016-0824-7
SSID ssj0000399364
Score 2.3653724
Snippet Exploring the potential of glycyrol to reduce the invasiveness of ( ). Cell experiments were performed using A549 alveolar epithelial cells and D39. Glycyrol...
Exploring the potential of glycyrol to reduce the invasiveness of Streptococcus pneumoniae (S. pneumoniae).Aim of the studyExploring the potential of glycyrol...
Aim of the studyExploring the potential of glycyrol to reduce the invasiveness of Streptococcus pneumoniae (S. pneumoniae).Materials and MethodsCell...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 1478135
SubjectTerms glycyrol
Pharmacology
PLY
Streptococcus pneumoniae
TCM
toxicity
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LixQxEA6yJy_i2_FFBFkUt9meTtKdHFVcF1GZwy6sF0Me1e7A2D3M9IDz761KZndmRPDitdNNF_VV6kEqXzH2so2hAa2wyAkyFNIIg3uuLIuqjUKhjQSVZh1--VqfnstPF-piZ9QX9YRleuCsuGMVyrFrXNkqYyRW6r6t2zHUuolRVGEM5H0x5u0UU8kHU9ytZb4lg1WYOW7nl474PyuJzqHR4zTfbRuJEmH_37LMP5sld6LPyW12a5M28rdZ3DvsBnR32eEk806vj_jZ9hrV8ogf8smWkXp9j33_OFuH9aKf8dz4veSTDlY_e6Ij6firyedvr3k_m_7o6fgm38vkQ88XROsKnA6u50OPnjOslnyevuymDvCVX9OAWfx9dn7y4ez9abEZrFAEVOFQBIUI-SaAa6WPJZTBmzbqGDFdhBIUDSB2XuG6rH0Vo3aYGVXCaa91MEGJB-yg6zt4xLjUyoMAIYRsJOrVCQGuRMxiVQejqhF7c6VkO8_8GRbrDoLEJkgsQWI3kIzYO8Lh-k3ivk4P0CLsxiLsvyxixF5coWhxr9ABiOugXy2twLBgFNZEzYg9zKhe_0qY2mCxiQLrPbz3ZNlf6aaXiY-bGIyoUH38P6R_wm6SRlLHjHjKDobFCp5h3jP458nEfwPjigQ0
  priority: 102
  providerName: Directory of Open Access Journals
Title Glycyrol targets Pneumolysin (PLY) oligomerization to reduce Streptococcus pneumoniae toxicity
URI https://www.ncbi.nlm.nih.gov/pubmed/39691402
https://www.proquest.com/docview/3146950497
https://pubmed.ncbi.nlm.nih.gov/PMC11650140
https://doaj.org/article/5c01a7a0f5994202bf6f1e687dd32c1e
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKuXBB5b0UKiOhCkQD3thO7AOqCqJUiKI9dKVywfIr7UrbZJtkpebfM3ayLYvKhWtsJ858Hs-MH98g9LpwNveCQ5BjmU2YpBJ0jpAkLRzlMEYsj7kOj39kR1P27ZSfbqBVuqNBgM2toV3IJzWt5--vLrt9UPiPIeIEe_uhWJzrQO2ZMtD7XIwpv4PugmXKQ0aD48HdjzNzsMYZ6-_O_KPpmn2KNP63-Z5_H6H8wyYdbqH7gzOJD3r0H6ANXz5Eu5Oejbrbwyc3l6uaPbyLJzc81d0j9OvrvLNdXc1xfxy8wZPSLy-qQFJS4jeT7z_f4mo-O6vCpk5_WxO3Fa4D2avHYTt70VYwn9plgxexZTnTHqpczSz49o_R9PDLyeejZEi3kFiWkjaxHHAzufW6YMYRT6yRhRPOgRPpiechLbE2HMpZZlLnhAZ_KaVaGCGstJw-QZtlVfpnCDPBjaeeUspyBnLVlHpNLBm7NLOSpyP0biVktehZNRREIwESFSFRARI1QDJCnwIO1zUDI3Z8UNVnalAwxeHtOtek4FLC76SmyIqxz0TuHE3t2I_QqxWKCjQobIvo0lfLRlEwFpJDpJSP0NMe1etPUZlJCEGhw2IN77W-rJeUs_PI0h14jUL4-vz_m26je0EO8fQMfYE223rpX4IP1JqduHawE4f3b9ErDG0
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Glycyrol+targets+Pneumolysin+%28PLY%29+oligomerization+to+reduce+Streptococcus+pneumoniae+toxicity&rft.jtitle=Frontiers+in+pharmacology&rft.au=Li%2C+Yudi&rft.au=Wu%2C+Hongji&rft.au=Hu%2C+Yibo&rft.au=Meng%2C+Haoji&rft.date=2024-12-03&rft.pub=Frontiers+Media+S.A&rft.eissn=1663-9812&rft.volume=15&rft_id=info:doi/10.3389%2Ffphar.2024.1478135&rft.externalDocID=PMC11650140
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon